SCHEMBL17063052

SCHEMBL17063052

C=COc1cc2ccccc2cc1OC=C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.38
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
ALOX12 P18054 2/20 0.36
MEN1 O00255 1/20 0.36
EGFR P00533 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36
JAK1 P23458 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
CYP2A6 P11509 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29591601 1.00 NQO1 (0.38) NQO1KDM4EALDH1A1HPGDALOX12
SCHEMBL16641117 0.84
SCHEMBL13899917 0.81 GPR84 (0.51) KDM4EALDH1A1HPGDALOX12MEN1
SCHEMBL194892 0.79 NQO1 (0.39) NQO1KDM4EALDH1A1HPGDALOX12
SCHEMBL29592755 0.78 ADRA2B (0.43) KDM4EALDH1A1HPGDTP53MAPK1
SCHEMBL3113317 0.78 ADRA2B (0.43) KDM4EALDH1A1HPGDTP53MAPK1
SCHEMBL29591550 0.78 ALDH1A1 (0.34) NQO1ALDH1A1HPGDMAPTHSD17B10
SCHEMBL17063030 0.78 ALDH1A1 (0.34) NQO1ALDH1A1HPGDMAPTHSD17B10
SCHEMBL1225166 0.76 CYP2A6 (0.52) KDM4EALDH1A1HPGDALOX12MEN1
SCHEMBL3111062 0.76 MAPT (0.57) NQO1KDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-12-05 US disclosed
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-11-21 US disclosed
US-12139567-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-11-12 US disclosed
US-12129335-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-10-29 US disclosed
US-20240239922-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-18 US disclosed
US-20240191003-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-11981794-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-05-14 US disclosed
EP-4317196-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-07 EP disclosed
US-20200292939-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PATTERNED RESIST FILM, METHOD OF MANUFACTURING SUBSTRATE WITH TEMPLATE AND METHOD OF MANUFACTURING PLATED ARTICLE TOKYO OHKA KOGYO CO., LTD. (JP) 2020-09-17 US disclosed
US-20200139433-A1 METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE FINE PARTICLE, METHOD FOR PRODUCING IMPROVED METAL OXIDE FINE PARTICLES, SURFACE-MODIFIED METAL OXIDE FINE PARTICLES, AND METAL OXIDE FINE PARTICLE DISPERSION LIQUID TOKYO OHKA KOGYO CO., LTD. (JP) 2020-05-07 US disclosed
US-10640607-B2 Curable composition, cured film, display panel, and method for producing cured product TOKYO OHKA KOGYO CO., LTD. (JP) 2020-05-05 US disclosed
US-10479879-B2 Curable composition, cured product of the curable composition, and method of producing a cured product using the curable composition TOKYO OHKA KOGYO CO., LTD. (JP) 2019-11-19 US disclosed
US-20190031818-A1 CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL OR OLED LIGHT, AND METHOD FOR PRODUCING CURED PRODUCT TOKYO OHKA KOGYO CO., LTD. (JP) 2019-01-31 US disclosed
US-20180334586-A1 CURABLE COMPOSITION, CURED PRODUCT, CURED FILM, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT TOKYO OHKA KOGYO CO., LTD. (JP) 2018-11-22 US disclosed
US-20180334533-A1 CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT TOKYO OHKA KOGYO CO., LTD (JP) 2018-11-22 US disclosed
US-20180251626-A1 CURABLE COMPOSITION, CURED PRODUCT OF THE CURABLE COMPOSITION, AND METHOD OF PRODUCING A CURED PRODUCT USING THE CURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2018-09-06 US disclosed
US-9683150-B2 Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 US disclosed
US-20150252229-A1 CURABLE COMPOSITION, ADHESIVE, METHOD OF PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL TOKYO OHKA KOGYO CO., LTD. (JP) 2015-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12139567-B2 Curable composition, cured product, and compound CROCC, RCSD1, CRYZ NQO1 2764/4885KDM4E 993/4885ALDH1A1 2462/4885
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 NQO1 4855/4885KDM4E 3845/4885ALDH1A1 1968/4885
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 NQO1 3808/4885KDM4E 1916/4885ALDH1A1 2515/4885
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 NQO1 3806/4885KDM4E 1918/4885ALDH1A1 2498/4885
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION PPOX, ERCC1, ERCC5 NQO1 769/4885KDM4E 727/4885ALDH1A1 1414/4885
US-12129335-B2 Curable composition, cured product, and compound CROCC, RCSD1, WDR5 NQO1 4263/4885KDM4E 705/4885ALDH1A1 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.